Penumbra Inc
Healthcare · EUR · F
Price
€282.802
Cap
€12.67B
Earnings
—
30d Trend
+0.3%
40% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 24×Macro 0.99 (−1%)=24
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 66 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
5-10 day swing — momentum continuation
BRAIN47'S ASSESSMENT
I rate Penumbra Inc at 24/100 — a VERY WEAK reading on the Brain47 Signal. The strongest factor is technical at 61/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
+27.8%
3 MONTHS
+4.5%
12 MONTHS
-19.3%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
5-10 day swing — momentum continuation. Technical (61) and low-risk profile are the primary strengths. I note that momentum is the weakest area at 10/100 — this warrants monitoring. Historical volatility is moderate at 40%. I classify this as a speculative position — risk characteristics and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.